Gilead Sciences, Inc.
GILD
$120.14
$0.120.10%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.21% | -11.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.22% | -11.92% | |||
| Cost of Revenue | -2.53% | -2.59% | |||
| Gross Profit | 8.86% | -14.38% | |||
| SG&A Expenses | 11.13% | -34.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.07% | -19.05% | |||
| Operating Income | 8.07% | 2.52% | |||
| Income Before Tax | 47.24% | -23.94% | |||
| Income Tax Expenses | 40.12% | -13.25% | |||
| Earnings from Continuing Operations | 49.05% | -26.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 49.05% | -26.25% | |||
| EBIT | 8.07% | 2.52% | |||
| EBITDA | 6.19% | 2.07% | |||
| EPS Basic | 49.17% | -26.13% | |||
| Normalized Basic EPS | 7.61% | 2.64% | |||
| EPS Diluted | 50.00% | -26.18% | |||
| Normalized Diluted EPS | 7.88% | 2.47% | |||
| Average Basic Shares Outstanding | -0.08% | -0.16% | |||
| Average Diluted Shares Outstanding | -0.32% | 0.00% | |||
| Dividend Per Share | 0.00% | 2.60% | |||
| Payout Ratio | -0.34% | 0.41% | |||